新澳门新葡萄娱乐(中國)官方網站Pro-One

Himsen Meikang joined hands with Zecheng Bio. Is the small chemiluminescence spring coming?

Xisen Meikang Medical Electronics (Shanghai) Co., Ltd. is the general agent of POClia in China.

Chemiluminescence, with its advantages of high sensitivity, good specificity, high degree of automation, good precision and high accuracy, has been rapidly promoted in clinical application and has become the leading technology of immunodiagnosis. The application of chemiluminescence immunoassay technology to POCT platform is a great breakthrough in technology. The effective combination of chemiluminescence immunoassay technology and POCT platform enables POCT platform to provide doctors with quick and convenient diagnostic reference, and at the same time has both sensitivity and accuracy of results, which enables doctors to realize real-time detection around patients, quickly obtain accurate diagnostic results, greatly improve the diagnostic efficiency and expand the application scenarios of inspection. Especially in some clinical application fields such as hospital ICU, emergency department, intracardiac department, chest pain center, etc., which require high accuracy and time of results, it can also enable small and medium-sized hospitals, social health centers, clinics, etc. to provide convenient and accurate diagnosis services for ordinary patients.

Compared with the large-scale lighting equipment in the central laboratory, POCT chemiluminescence is small, flexible and easy to operate, which is suitable for the application scenarios of POCT. Compared with the traditional immunocolloidal gold and immunofluorescence POCT products, the methodology is more advanced, which can ensure the higher sensitivity and accuracy of the project. Therefore, the market potential of chemiluminescence POCT has been fully recognized, among which the single POCT chemiluminescence liquid-free system can realize whole blood detection, no waste of detection reagents, follow-up measurement and simple operation, and has four "killing techniques" of "accurate, stable, fast and economical". 

Kill skill one: accurate

The results are accurate and have the same quality control and calibration as large-scale chemiluminescence platform, which is an important advantage of single chemiluminescence. At present, most POCT products on the market can solve the problem of rapid detection, but their detection results cannot meet the increasing clinical requirements for detection sensitivity and precision. False positive and false negative results not only interfere with doctors' diagnosis, but also lead to waste of medical resources due to repeated examinations. The small linear range and poor repeatability can't well monitor the therapeutic effect, so the clinic calls for POCT products with accurate detection results.

Chemiluminescence detection results are more sensitive and accurate, which can meet the clinical demand for high-quality detection results. Each test item is equipped with its corresponding quality control products and calibrators, which overcomes the defects of lack or inconvenience of quality control calibration of traditional POCT platform, so that POCT can implement the same quality management requirements as large-scale lighting equipment in central laboratory.

Skill 2: Stable 

Single POCT chemiluminescence detection technology platform has no internal liquid circuit structure, low failure rate and stable instrument; All the reaction and cleaning steps were completed on one reagent strip, without cross contamination, and the results were stable.

Skill 3: Quick

Besides "accuracy and stability", from the user's point of view, what other aspects do they pay attention to? The convenience of operation and timeliness of results are undoubtedly very important, such as detection speed, whole blood sampling, simple operation, etc., which are all important factors affecting the application experience of chemiluminescence POCT. Single POCT chemiluminescence can realize multi-channel and multi-item simultaneous detection, which is easy to operate.

Whole blood sampling is the objective demand of users for POCT detection products. Therefore, whether the whole blood can be sampled or not is a great challenge for POCT chemiluminescent products to realize the substitution of fluorescence immunoassay methodology. After the research and development and technical improvement of various manufacturers, some manufacturers have realized the ischemia detection of myocardial, inflammation, maternal and child items, and gained market opportunities.

Kill skill four: save

The trial scenes of POCT, such as hospital ICU, emergency department, cardiac center, chest pain center, social health center and clinic, have limited sample size, and the detection amount can't be compared with that of central laboratory. It is expensive to adopt large-scale light-emitting platform. Firstly, it needs to be equipped with high-cost detection equipment and supporting facilities; Secondly, in the process of use, the bottled reagents with large luminous intensity often face the situation of "expiration before use up"; In the calibration and quality control stage, reagents will be consumed, resulting in high cost; All kinds of general reagents and consumables are not small costs. Single POCT Chemiluminescence Reagents are individually packaged, which can be removed immediately after use, completely eliminating reagent waste. At the same time, there is no need for consumables, hidden cost and bottle opening validity limit, which greatly saves the detection cost.

Zecheng Bio is an in vitro diagnostic enterprise established in August, 2011, which takes the overall solution of fully automatic chemiluminescence as the leading factor. It applies many years' research and development and production experience of large-scale chemiluminescence products to POCT field, innovatively integrates, and introduces single-serving fully automatic chemiluminescence products, which takes into account the flexible operation of small-scale POCT products and the quality level of chemiluminescence detection system, and meets the rigid demand for high-quality POCT products. The detection items cover myocardial markers-—NT proBNP, myocardial infarction triple, H-FABP, HCY, DD; Infection markers-—PCT, IL-6; Nutritional status detection —25(OH)VD, Fer, VitB12, FA; Sex hormones-progesterone, β-HCG; Stomach function —PGI/PGII, etc. The sample types cover whole blood, plasma, serum, etc.

Zecheng Bio is an in vitro diagnostic enterprise established in August, 2011, which takes the overall solution of fully automatic chemiluminescence as the leading factor. It applies many years' research and development and production experience of large-scale chemiluminescence products to POCT field, innovatively integrates, and introduces single-serving fully automatic chemiluminescence products, which takes into account the flexible operation of small-scale POCT products and the quality level of chemiluminescence detection system, and meets the rigid demand for high-quality POCT products. The detection items cover myocardial markers-—NT proBNP, myocardial infarction triple, H-FABP, HCY, DD; Infection markers-—PCT, IL-6; Nutritional status detection —25(OH)VD, Fer, VitB12, FA; Sex hormones-progesterone, β-HCG; Stomach function —PGI/PGII, etc. The sample types cover whole blood, plasma, serum, etc. 

Xisen Meikang Medical Electronics (Shanghai) Co., Ltd. is the general agent of POClia in China.